Literature DB >> 14988590

Role of thrombospondin-1 in the autologous phase of an accelerated model of anti-glomerular basement membrane glomerulonephritis.

Kathrin Hochegger1, Sara Knight, Christian Hugo, Gert Mayer, Jack Lawler, Tanya N Mayadas, Alexander R Rosenkranz.   

Abstract

BACKGROUND: Thrombospondin-1 (TSP1), a multifunctional, extracellular matrix protein, regulates cellular attachment, proliferation, migration, and differentiation in vitro, and is expressed de novo in many inflammatory diseases, including glomerulonephritis (GN).
METHODS: We investigated the role of TSP1 in the autologous phase of an accelerated model of anti-glomerular basement membrane (GBM) GN in mice deficient in TSP1. The model, induced by the injection of rabbit anti-mouse GBM antibody, is characterized by the development of proteinuria and glomerular damage over a 21-day observation period in wild-type mice.
RESULTS: Mice deficient in TSP1 developed significantly less proteinuria than their wild-type controls 21 days after induction of disease (5,793 +/- 5,456 vs. 24,293 +/- 15,336 microg albumin/mg creatinine; p = 0.002). Serum creatinine levels were significantly higher in the wild-type mice than in the TSP1 deficient animals (29.03 +/- 2.34 vs. 16.39 +/- 2.87 micromol/l; p = 0.005). Other disease indices as crescent formation, fibrin deposition and macrophage influx, were also diminished in the TSP1 knockout animals. The numbers of interstitial CD4+ and CD8+ T cells were generally less in TSP1-deficient mice and reached statistical significance in CD4+ (p = 0.01) and CD8+ T cells (p = 0.02). The difference in outcome of the disease was not due to the difference in deposition/production of heterologous and autologous antibodies in the two groups of animals.
CONCLUSION: This study suggests a proinflammatory role of TSP1 in an experimental model of GN. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988590     DOI: 10.1159/000076402

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  3 in total

1.  Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis.

Authors:  Sohel M Julovi; Barkha Sanganeria; Nikita Minhas; Kedar Ghimire; Brian Nankivell; Natasha M Rogers
Journal:  Lab Invest       Date:  2020-05-04       Impact factor: 5.662

2.  Thrombospondin-1 deficiency causes a shift from fibroproliferative to inflammatory kidney disease and delays onset of renal failure.

Authors:  Michael Zeisberg; Björn Tampe; Valerie LeBleu; Desiree Tampe; Elisabeth M Zeisberg; Raghu Kalluri
Journal:  Am J Pathol       Date:  2014-08-10       Impact factor: 4.307

Review 3.  The thrombospondins.

Authors:  Josephine C Adams; Jack Lawler
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-10-01       Impact factor: 10.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.